Blue Cap AG, a Munich-based investment company specializing in medium-sized B2B businesses, has announced a major change to its Management Board. Dr. Henning von Kottwitz, Chairman of the Management Board, will leave the company effective October 8, 2026, by mutual agreement with the Supervisory Board. This transition comes at a time when Blue Cap AG is strategically positioned to capitalize on market opportunities, and the appointment of Dr. Christian Diekmann as a Management Board member is set to ensure continuity and drive further growth.
According to the press release, the Supervisory Board has resolved to second its Chairman, Dr. Christian Diekmann, to the Management Board as a member effective October 9, 2026, pursuant to Section 105(2) of the German Stock Corporation Act (AktG). Dr. Diekmann will be responsible for strategy and finance, leveraging his extensive experience in operational restructuring and management of medium-sized corporate groups. He has been Chairman of the Supervisory Board since 2024 and previously served as CEO of Max Automation SE and CFO of Zertus Group.
The departure of Dr. von Kottwitz marks the end of a tenure that saw significant transactions and positioned Blue Cap AG for future development. The Supervisory Board expressed its gratitude for his service and commitment. Dr. Michael Schieble, Deputy Chairman of the Supervisory Board, commented, “We are very pleased that Dr. Christian Diekmann has agreed to drive the further development of Blue Cap AG’s business model as a member of the Management Board in the near term and take it to the next level.”
Dr. Diekmann’s deep understanding of Blue Cap’s potential as a listed investment company pursuing the successful Buy-Transform-Sell strategy is expected to be instrumental. He stated, “Blue Cap AG is ideally positioned as an investor in ‘special situations’ to grow in the current economic environment. Many companies that are fundamentally well positioned for the future are increasingly affected by disruptions in industry and structural challenges. We aim to address these challenges through our business model, strengthen Germany as an industrial location and create value for our shareholders.”
In addition to Dr. Diekmann’s appointment, Henning Eschweiler will remain on the Management Board as COO, continuing to oversee operational portfolio management and assuming responsibility for M&A. This dual leadership structure is designed to maintain stability and focus on both operational and strategic initiatives.
Blue Cap AG, founded in 2006, acquires medium-sized B2B companies in special situations, supports their development, and aims to sell them at a profit. With six portfolio companies in plastics engineering, production engineering, pre-press solutions, life sciences, and business services, the group employs around 2,000 people across Germany, Europe, North America, and Asia. The company’s shares are traded on the Open Market (Scale, Frankfurt, and m:access, Munich; ISIN: DE000A0JM2M1; ticker symbol: B7E).
This leadership change is significant as it signals Blue Cap’s commitment to its strategic vision and adaptability in a challenging economic landscape. The transition is expected to be smooth, given Dr. Diekmann’s familiarity with the company and his proven track record. Stakeholders can view the original release on www.newmediawire.com and find more information at www.blue-cap.de. This announcement is important as it highlights Blue Cap’s proactive approach to leadership and its focus on creating shareholder value through its Buy-Transform-Sell strategy.
